StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $0,25 coming

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Dec 23, 2021 2:05pm

129 Views

Post# 34258730

RE:RE:$0,25 coming

so this history you like but the history of
$30M in revenue and didnt even get $300K in revenue we should all forget about eh?

We should forget about oncore and ibodycheck too

We should forget about return to Q1 covid revenue for Q3

But oh dont you dare forget about 6 weeks after a PP thats where the value goes to.

Do as I say or your wrong. Thats what you are saying.

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army